A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer

Clinical trial NCT06312982 · RECRUITING

Trial details

NCT number: NCT06312982
Sponsor: Beijing Friendship Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Locally Advanced Rectal Carcinoma

Start date: 2024-03-16
Primary completion: 2026-12-01
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.